[1]
Cerier E, Beal EW, Dillhoff ME. Inflammatory myofibroblastic tumour: an unusual presentation
including small bowel obstruction and palpable abdominal mass. BMJ Case Rep. 2018.
2018.
[2]
Roth JA. Reactive pseudosarcomatous response in urinary bladder. Urology. 1980. 16(6):
635-7.
[3]
Coffin CM, Watterson J, Priest JR, Dehner LP. Extrapulmonary inflammatory myofibroblastic
tumor (inflammatory pseudotumor). A clinicopathologic and immunohistochemical study
of 84 cases. Am J Surg Pathol. 1995. 19(8): 859-72.
[4]
Rotenberry C, Dowd K, Russell D, DeRiese W, Teeple S, Cammack T. Robot-assisted Partial
Cystectomy for Treatment of Inflammatory Myofibroblastic Tumor of the Bladder. Urol
Case Rep. 2017. 11: 25-27.
[5]
Tao YL, Wang ZJ, Han JG, Wei P. Inflammatory myofibroblastic tumor successfully treated
with chemotherapy and nonsteroidals: a case report. World J Gastroenterol. 2012. 18(47):
7100-3.
[6]
Montgomery EA, Shuster DD, Burkart AL, et al. Inflammatory myofibroblastic tumors
of the urinary tract: a clinicopathologic study of 46 cases, including a malignant
example inflammatory fibrosarcoma and a subset associated with high-grade urothelial
carcinoma. Am J Surg Pathol. 2006. 30(12): 1502-12.
[7]
Telugu RB, Prabhu AJ, Kalappurayil NB, Mathai J, Gnanamuthu BR, Manipadam MT. Clinicopathological
Study of 18 Cases of Inflammatory Myofibroblastic Tumors with Reference to ALK-1 Expression:
5-Year Experience in a Tertiary Care Center. J Pathol Transl Med. 2017. 51(3): 255-263.
[8]
Teoh JY, Chan NH, Mak SM, et al. Inflammatory myofibroblastic tumours of the urinary
bladder: multi-centre 18-year experience. Urol Int. 2015. 94(1): 31-6.
[9]
Kapusta LR, Weiss MA, Ramsay J, Lopez-Beltran A, Srigley JR. Inflammatory myofibroblastic
tumors of the kidney: a clinicopathologic and immunohistochemical study of 12 cases.
Am J Surg Pathol. 2003. 27(5): 658-66.
[10]
Teoh JY, Chan NH, Cheung HY, Hou SS, Ng CF. Inflammatory myofibroblastic tumors of
the urinary bladder: a systematic review. Urology. 2014. 84(3): 503-8.
[11]
Rosenberg AE. WHO Classification of Soft Tissue and Bone, fourth edition: summary
and commentary. Curr Opin Oncol. 2013. 25(5): 571-3.
[12]
Tazi K, Ehirchiou A, Karmouni T, et al. [Inflammatory pseudotumors of the kidney:
a case report]. Ann Urol (Paris). 2001. 35(1): 30-3.
[13]
Ishikawa T, Fujisawa M, Tamada H, Inoue T, Shimatani N. Inflammatory pseudotumor of
the kidney. Int J Urol. 2004. 11(5): 337-9.
[14]
Bildirici K, Dönmez T, Gürlek E. Inflammatory pseudotumor of the kidney. Int Urol
Nephrol. 2004. 36(2): 141-3.
[15]
Lee NG, Alexander MP, Xu H, Wang DS. Renal Inflammatory Myofibroblastic Tumor: A Case
Report and Comprehensive Review of Literature. World J Oncol. 2011. 2(2): 85-88.
[16]
Jenkins LC, Whittington E, Ciancio G, Jorda M. Inflammatory myofibroblastic tumor
of the kidney. J Urol. 2013. 189(6): 2310-1.
[17]
Harik LR, Merino C, Coindre JM, Amin MB, Pedeutour F, Weiss SW. Pseudosarcomatous
myofibroblastic proliferations of the bladder: a clinicopathologic study of 42 cases.
Am J Surg Pathol. 2006. 30(7): 787-94.
[18]
Liang W, Zhou X, Xu S, Lin S. CT Manifestations of Inflammatory Myofibroblastic Tumors
(Inflammatory Pseudotumors) of the Urinary System. AJR Am J Roentgenol. 2016. 206(6):
1149-55.
[19]
Cessna MH, Zhou H, Sanger WG, et al. Expression of ALK1 and p80 in inflammatory myofibroblastic
tumor and its mesenchymal mimics: a study of 135 cases. Mod Pathol. 2002. 15(9): 931-8.
[20]
Freeman A, Geddes N, Munson P, et al. Anaplastic lymphoma kinase (ALK 1) staining
and molecular analysis in inflammatory myofibroblastic tumours of the bladder: a preliminary
clinicopathological study of nine cases and review of the literature. Mod Pathol.
2004. 17(7): 765-71.
[21]
Hickman RA, Alexander M, Provet J, Melamed J, Deng FM. Inflammatory myofibroblastic
tumour of the testis with confirmed anaplastic lymphoma kinase gene rearrangement.
Histopathology. 2016. 68(7): 1109-11.